Related references
Note: Only part of the references are listed.HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
G. L. Semenza
CURRENT PHARMACEUTICAL DESIGN (2009)
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
William Y. Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Human cancers converge at the HIF-2α oncogenic axis
Aleksandra Franovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma
John D. Gordan et al.
CANCER CELL (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis
Julian J. Lum et al.
GENES & DEVELOPMENT (2007)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
Acute postnatal ablation of Hif-2α results in anemia
Michaela Gruber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hypoxia-inducible factors: central regulators of the tumor phenotype
John D. Gordan et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression
Debbie Liao et al.
CANCER RESEARCH (2007)
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers
QT Le et al.
CLINICAL CANCER RESEARCH (2006)
HIN-1, an inhibitor of cell growth, invasion, and AKT activation
I Krop et al.
CANCER RESEARCH (2005)
Genetic evidence for a tumor suppressor role of HIF-2α
T Acker et al.
CANCER CELL (2005)
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma
RR Raval et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies
H Shigematsu et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome
A Marchetti et al.
CLINICAL CANCER RESEARCH (2004)
Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
AL Kung et al.
CANCER CELL (2004)
Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer
DEB Swinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Inhibition of HIF2 alpha is sufficient to suppress pVHL-defective tumor growth
K Kondo et al.
PLOS BIOLOGY (2003)
Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues
D Porter et al.
MECHANISMS OF DEVELOPMENT (2002)
The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma
JK Maranchie et al.
CANCER CELL (2002)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
A Giatromanolaki et al.
BRITISH JOURNAL OF CANCER (2001)
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells
IE Krop et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Suppression of tumor growth through disruption of hypoxia-inducible transcription
AL Kung et al.
NATURE MEDICINE (2000)
Share Paper
